Compare RLMD & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLMD | XYF |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.3M | 260.6M |
| IPO Year | N/A | 2018 |
| Metric | RLMD | XYF |
|---|---|---|
| Price | $4.42 | $6.76 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 250.8K |
| Earning Date | 11-13-2025 | 11-20-2025 |
| Dividend Yield | N/A | ★ 8.29% |
| EPS Growth | N/A | ★ 49.84 |
| EPS | N/A | ★ 5.72 |
| Revenue | N/A | ★ $1,106,908,607.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.21 |
| Revenue Growth | N/A | ★ 47.14 |
| 52 Week Low | $0.24 | $6.47 |
| 52 Week High | $5.12 | $20.36 |
| Indicator | RLMD | XYF |
|---|---|---|
| Relative Strength Index (RSI) | 66.71 | 23.96 |
| Support Level | $3.95 | $6.66 |
| Resistance Level | $4.60 | $7.48 |
| Average True Range (ATR) | 0.43 | 0.54 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 80.00 | 7.99 |
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.